Marvell reported second-quarter fiscal 2027 results after the close on 27 August. The rating stays at Watchlist, with fair value raised from $202 to $229 and the investment score from 62 to 66.

The quarter itself was thin. Revenue of $2.739 billion rose 37% year on year against a $2.72 billion consensus, a beat of less than a percent. Non-GAAP earnings of $0.94 landed a single cent above both the guidance midpoint and the street. For a stock that had climbed 121% from its April low, into a market increasingly worried that artificial-intelligence capital spending has run ahead of itself, meeting expectations was not enough. The shares fell as much as 7% in extended trading. They had already reversed during the session, opening at $253.44 and closing at $241.45 near the day’s low on 1.73 times average volume.

The guidance was a different matter. Third-quarter revenue is guided to $3.15 billion, up 15% sequentially and more than 50% year on year. Fiscal 2027 revenue rose to roughly $12 billion and fiscal 2028 to roughly $18 billion, a $1.5 billion increase to a target that had itself been lifted one quarter earlier. Growth for fiscal 2028 is now guided near 50% against a prior 45%. Chairman and Chief Executive Matt Murphy framed it plainly: even as the revenue base becomes significantly larger, the growth rate is accelerating.

An expanded agreement and warrant with a major hyperscaler drew most of the questions. It spans inference accelerators, storage controllers, network interface controllers, memory interface controllers and near-memory compute, and validates the attached-silicon category Marvell largely created. It also, on management’s own account, adds nothing to the numbers through fiscal 2028, because that revenue was already in the outlook. The benefit sits in fiscal 2029, and it deepens a customer concentration that was already the central risk here.

Operating margin is the number to watch next. Third-quarter gross margin is guided down to 57.5% to 58.5% because custom silicon ramps at lower margin, with management arguing operating margin still expands into the 38% to 40% band by the fourth quarter. That is testable.

At $241.45 the shares trade near 37 times an estimated fiscal 2028, against a larger competitor near 20 to 24 times. Fair value at $229 sits 5.1% below the price. The accumulation zone moves up to $180 to $200.

Scenario detail, the risk table and the full trade plan appear in the complete Marvell Technology (MRVL) report on our Reports page.